Amgen/Cytokinetics Phase III Heart Failure Data Are Below Expectations
Omecamtiv Met Primary, Missed Key Secondary Endpoints
Omecamtiv reduced a composite of hospitalizations and deaths with no significant impact on deaths alone • Source: Shutterstock 
